VOTE NO. AWAIT "BEST & FINAL" DECLARATION, page-280

I found this heading in The Australian. Apologies if it has been posted previously. Snippet attached. I also just voted No for our 6 accounts.

ISS urges shareholders of Covid-19 cough detection outfit ResApp to take Pfizer’s $180m.

Institutional Shareholder Services has backed Pfizer’s $179m takeover of a fledgling biotech which is developing an app to detect Covid-19 via coughing into a smartphone.

Despite a block of ResApp investors voicing opposition to the deal, which the company’s board has backed, the proxy advisory group said the buyout’s benefits outweighed its disadvantages.

ISS said Pfizer’s offer “provides certainty against the risks associated with the execution of ResApp‘s long-term strategy”.